Allowance of United States Patent
Filed with ASX · · 2 pages · English
• US Patent Office issues Notice of Allowance to grant additional new patent • Patent relates to use of Bio-Gene molecules to control resistant pests • Along with other recent grants, this extends patent protection for Bio-Gene’s technology to 2038 and further supports its core value proposition Bio-Gene Technology Limited (ASX: BGT, ‘Bio-Gene’ or ‘the ‘Company’), an agtech development company ena
Bio-Gene Technology Ltd. on 6ix
Story so far
Earlier from Bio-Gene Technology
- Bio-Gene Company Update Presentation
- Appendix 4D - Half Year Accounts - 31 December 2022
- Appendix 4C - 31 December 2022
- Bio-Gene and STK Agree Binding Terms on Global Collaboration
- Bio-Gene Submits Application for Plant Breeders Rights
Later from Bio-Gene Technology
- Bio-Gene Extends Commercial Development Agreement
- Board and Management Changes
- Synergy Studies Offer Significant Commercial Opportunities
- Appendix 4C - 31 March 2023
- GRDC Confirms Support for Flavocide in Grain Storage
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology